FDA Inspection 1153209 — Paratek Pharmaceuticals, Inc.
The FDA completed an inspection of Paratek Pharmaceuticals, Inc. on September 1, 2021 in King Of Prussia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 1, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- King Of Prussia, PA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)